Financhill
Back

Amedisys 10K Form

Buy
70

AMED
Amedisys

Last Price:
$96.00
Seasonality Move:
8.54%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive AMED News And Ratings

See the #1 stock for the next 7 days that we like better than AMED

AMED Financial Statistics

Sales & Book Value

Annual Sales: $2.3B
Cash Flow: $-5.1M
Price / Cash Flow: 14.55
Annual Sales: $36.55
Price / Book: 2.63

Profitability

EPS (TTM): 2.71000
Net Income (TTM): $89.8M
Gross Margin: $1B
Return on Equity: 7.55%
Return on Assets: 4.21%

Amedisys Earnings Forecast

Key Amedisys Financial Ratios

  • The Gross Profit Margin over the past 32 years for AMED is 43.34%.
  • The Selling, General & Administrative Expenses for AMED have been equal to 33.65% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 71.16% of Operating Income.
  • The Net Earning history of AMED is 1.84% of Total Revenues.
  • Per Share Earnings over the last 32 years have been positive in 18 years.

Amedisys Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: AMED
CUSIP: 023436
Website: amedisys.com

Debt

Debt-to-Equity Ratio: 0.31
Current Ratio: 1.29
Quick Ratio: 1.23

Price-to-Earnings

Trailing P/E Ratio: 73.28
Forward P/E Ratio: 18.56

AMED Technical Analysis vs Fundamental Analysis

Buy
70
Amedisys (AMED) is a Buy

Is Amedisys a Buy or a Sell?

  • Amedisys stock is rated a Buy
    The current Amedisys [AMED] share price is $96.00. The Score for AMED is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.